Business Context and Reporting Period
This Form 6-K filing by MediWound Ltd. covers the extraordinary general meeting of shareholders held on February 22, 2018. The Company is a foreign private issuer based in Yavne, Israel, and files annual reports on Form 20-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance.
Material Changes
There are no material financial changes reported in this document. The primary event is the successful approval of three shareholder proposals that were previously detailed in a proxy statement filed on January 16, 2018.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or discussion of risks and contingencies. It confirms that the meeting was properly convened with a quorum present, and all proposals were approved in accordance with Israeli Companies Law and the Company's Articles of Association.
Key Facts for Investor Verification
- Shareholder Participation: 14,868,815 ordinary shares were present in person or by proxy, representing 55% of the 27,047,737 shares outstanding as of the January 22, 2018 record date.
- Voting Outcome: All three proposals presented at the meeting were approved.
- Reference Document: Details regarding the specific proposals are located in the proxy statement attached as Exhibit 99.1 to the Form 6-K filed on January 16, 2018.
- Financial Data: No financial metrics are included in this specific filing.